Despite increasing evidence suggests that serotonin (5-HT) can influence neurogenesis, neuronal migration and circuitry formation, the precise role of 5-HT on central nervous system (CNS) development is only beginning to be elucidated. Moreover, how changes in serotonin homeostasis during critical developmental periods may have etiological relevance to human mental disorders, remains an unsolved question. In this study we address the consequences of 5-HT synthesis abrogation on CNS development using a knockin mouse line in which the tryptophan hydroxylase 2 (Tph2) gene is replaced by the eGFP reporter. We report that lack of brain 5-HT results in a dramatic reduction of body growth rate and in 60% lethality within the first 3 weeks after birth, with no gross anatomical changes in the brain. Thanks to the specific expression of the eGFP, we could highlight the serotonergic system independently of 5-HT immunoreactivity. We found that lack of central serotonin produces severe abnormalities in the serotonergic circuitry formation with a brain region-and time-specific effect. Indeed, we observed a striking reduction of serotonergic innervation to the suprachiasmatic and thalamic paraventricular nuclei, while a marked serotonergic hyperinnervation was found in the nucleus accumbens and hippocampus of Tph2HeGFP mutants. Finally, we demonstrated that BDNF expression is significantly up-regulated in the hippocampus of mice lacking brain 5-HT, mirroring the timing of the appearance of hyperinnervation and thus unmasking a possible regulatory feedback mechanism tuning the serotonergic neuronal circuitry formation. On the whole, these findings reveal that alterations of serotonin levels during CNS development affect the proper wiring of the brain that may produce long-lasting changes leading to neurodevelopmental disorders.
INTRODUCTION
Serotonin (5-HT) is a neurotransmitter implicated in the modulation of numerous physiological processes including mood, sleep, aggressivity and sexual behavior. [1] [2] [3] [4] Serotonergic neurons represent one of the most early-born and widely distributed neuronal systems in the mammalian brain. These neurons collectively form the raphe system and cluster in distinct nuclei (B1-B9) providing a widespread serotonergic innervation to the whole central nervous system (CNS). 5, 6 The synthesis of 5-HT and the expression of its receptors early in embryonic development, as well as its maternal and placental source to the fetus, has led to the hypothesis that serotonin could act as a growth regulator in specific developmental events. [7] [8] [9] [10] Support for a role of 5-HT in brain development comes from the idea that dysregulation of serotonergic signaling is at the origin of disorders thought to have developmental bases, such as schizophrenia, affective disorders, anxiety, autism and mental retardation. [11] [12] [13] Genetic models in mice indicated that excess of brain 5-HT levels obtained by knocking-out the serotonin transporter (Slc6a4) or monoamine oxydase-A (MAO-A), genes involved in 5-HT re-uptake and degradation, respectively, prevents the development of topographically organized whisker-barrel fields in the mouse somatosensory cortex. 14, 15 Further, recent findings showed that increased 5-HT transmission could also alter normal cortical development causing incorrect interneuron migration. 16 Taken together these observations indicated that normal 5-HT neurotransmission is required for a correct brain development. On the other hand, analysis of mouse models lacking most serotonergic neurons, obtained inactivating genes involved in the specification of 5-HT identity, such as Lmx1b and Pet1, failed to show brain malformations. 17, 18 Recently, animal models with targeted inactivation of tryptophan hydroxylase 2 (Tph2), the rate-limiting enzyme for the synthesis of central 5-HT, have been generated. [19] [20] [21] [22] [23] In different genetic models, serotonin depletion consistently resulted in physiological and behavioral disturbances. 19, [22] [23] [24] However, lack of serotonin in Tph2 knockout mouse lines did not produce any gross cellular or morphological alteration in the CNS. How can these results be reconciled with the developmental role ascribed to serotonin? On one side, maternal availability of serotonin during early fetal life to the developing brain may explain the absence of overt CNS morphological defects. 7, 8 On the other, it can be hypothesized that lack of brain serotonin may selectively affect fine tuning modulation of developmental events, whose alterations would require subtle analysis at cellular level.
In this regard, the present work aims to investigate whether constitutive depletion of brain serotonin might affect development of the CNS and/or the serotonergic system itself. To this purpose we genetically introduced the enhanced green fluorescent protein (eGFP) into the Tph2 locus in a way to highlight the serotonergic neurons independently of serotonin immunoreactivity. Overall, we report that Tph2HeGFP À / À mice show a reduced body growth rate and a high mortality level and, most importantly, we found for the first time that lack of serotonin produces severe abnormalities in the serotonergic circuitry formation with a brain region-and time-specific effect.
MATERIALS AND METHODS

Generation of the Tph2HeGFP knock-in mouse alleles
Tph2HeGFP
(FRT-neo-FRT) knock-in recombinant allele was generated by homologous recombination in E14Tg2a.4 embryonic stem (ES) cell line. 25 The targeting vector was prepared replacing 105 nucleotides of Tph2 gene downstream the first ATG codon with the cDNA coding for the vital reporter gene eGFP starting with its second codon. A selection marker cassette, flanked by FRT sites, was placed 3 0 to the eGFP cDNA in the opposite transcriptional orientation. We obtained the BamHI-ClaI genomic fragment (pBKS-Tph2-BC) containing 3.3 and 3.9 kb upstream and downstream the first ATG codon of the Tph2 gene, respectively. To generate the Tph2HeGFP (FRT-neo-FRT) targeting vector we used a recombination-based strategy carried out in DY380 bacteria. 26 Two 500 bp long homology arms (HAs) were generated by PCR amplification of mouse pBKS-Tph2-BC plasmid DNA using the following primer sets: forward 5 0 -ATTATTGGATCCGAATTCATAATGTAACGTCATGCCAGCAGA-3 0 and reverse 5 0 -ATTATTCCATGGCTCCCGATGTAATTTTCTTT-3 0 for the 5 0 homology arm, and forward 5 0 -ATTATTCTCGAGTATCGAGTATCTGGCAGTCTCCG-3 0 and reverse 5 0 -ATTATTGTCGACGAATTCTGCTTCCTTAACTCTTCCATCAATTA-3 0 for the 3 0 homology arm. To obtain the p-5HA/eGFP/3HA vector, the 5 0 and 3 0 homology arms were subcloned as BamHI-NcoI and XhoI-SalI fragments into the BglII-NcoI and XhoI sites of the pIRES-eGFP vector (Clontech), respectively. A removable neo selection cassette, 27 was cloned into the XhoI site of the p-5HA/eGFP/3HA plasmid to generate the p-5HA/ eGFP/FRT-neo-FRT/3HA vector. p-5HA/eGFP/FRT-neo-FRT/3HA and pBKSTph2-BC were co-electroporated in DY380 E. coli following standard protocols previously described 26 to obtain the Tph2HeGFP
targeting vector. The NotI linearized Tph2HeGFP (FRT-neo-FRT) targeting construct was electroporated into E14Tg2a.4 ES cells (BioRad Gene Pulser Unit, 3 mF/800 V) and neomycin selection was maintained for 7 days. Neomycin-resistant cells were screened for the homologous recombination event using Southern blot analysis. Of 96 neomycinresistant clones, four clones resulted to have the desired integration within the Tph2 locus. Two independent Tph2HeGFP
(FRT-neo-FRT) ES cell clones were injected into C57BL/6 host blastocysts and implanted into pseudopregnant females to generate chimeric mice. Germline transmission was obtained from two male chimeras and the Tph2HeGFP (FRT-neo-FRT) mouse line was established on mixed (129/Ola-C57BL/6), 129/Ola, and C57BL/6 (backcrossed onto C57BL/6 wild-types for at least 9 generations) genetic background. Tph2HeGFP
(FRT-neo-FRT) heterozygous mice were mated to the ACTBHFLPe deleter 28 For each experiment, littermates of the analyzed animals were used as control. Where not otherwise specified, mice on C57BL/6 genetic background were used and at least three animals per genotype from three distinct litters were used.
HPLC measurements
Animals were sacrificed by decapitation and brain tissue samples were rapidly dissected out and frozen at À 80 1C until analysis. For the determination of serotonin content, frozen tissue was homogenized in lysis buffer containing 10 mM ascorbic acid and 2.4% perchloric acid. Brain tissue levels of serotonin were measured using HPLC with electrochemical detection (HPLC-ECD).
Evans blue dye assay
Evans blue dye method was used to calculate the circulating cerebral blood volume (CBV) in Tph2HeGFP mutant animals according to the procedure described in Uyama et al. 29 Briefly, 1% Evans blue (Sigma Aldrich, St Louis, MO, USA) in phosphate-buffered saline (PBS, pH 7.5) was injected into the tail vein of adult mice. Animals were sacrificed by decapitation 5 min after injection and whole blood, forebrain and hindbrain tissues were quickly collected, weighted, homogenized in a five-fold volume of 50% trichloroacetic acid (w/v) solution, and centrifuged at 12 000 r.p.m. for 20 min. Supernatants were diluted with ethanol (1:3) and absorbance of extracted dye was measured at 620 nm using a spectrophotometer. Volume calculations were based on Evans blue dye standards dissolved in whole blood (0.01-1 mg/ml) and processed in parallel to tissue samples. CBV was calculated per milligram of forebrain and hindbrain tissue samples and used to assess blood-derived 5-HT content in brain tissue of Tph2HeGFP mutant animals ( Figure 3f ).
Histological, immunohistochemical and in situ hybridization analyses For cytochrome oxidase (CO) histochemical staining Tph2HeGFP mutant and wild-type samples were processed following standard protocols. Briefly, brains were dissected from P10 littermates and cerebral hemispheres were removed and flattened between two glass slides separated by spacers. After 48 h of fixation in 4% PFA, specimens were equilibrated in 30% sucrose and cut 60 mm thick on the vibratome parallel to the pial surface. The CO activity was visualized incubating in the dark o/n at 37 1C with a solution containing 0.04% cytochrome C, 0.05% diaminobenzidine, 4% sucrose in PBS. Sections were rinsed in PBS, mounted onto glass slides and coverslipped with PBS containing 50% glycerol. The entire barrel field was reconstructed from serial CO-stained tangential sections, when necessary.
For in situ hybridization analysis, fresh brain tissue was embedded in Tissue Tek (Sakura), and frozen at À 80 1C. 14 mm cryostat sections were cut in the coronal plane and in situ hybridization was performed according to protocols using either digoxigenin-labeled (eGFP, 0.7 Kb; Tph2, 1.5 Kb full coding sequence cloned by PCR using the following primers:
S-labeled (BDNF, 0.5 Kb) antisense RNA probes as previously described. 30, 31 In digoxigenin-labeled in situ hybridization experiments, NBT/BCIP (Roche) was used as substrate for alkaline phosphatase, while in radioactive in situ hybridization, sections were exposed to Biomax MR X-ray films (Kodak) for two to four days. For each probe or antibody used, sections from different genotypes were processed in parallel in order to minimize the experimental variability. Images were taken with Eclipse E600 or Eclipse Ti microscopes (Nikon) equipped with DS-SMc digital cameras (Nikon), with a MacroFluo microscope (Leica) or with a SP5 confocal microscope (Leica). For Large field-of-view imaging the image stitching application of Nikon NIS-Elements software was used. Thickness of confocal sections was optimized for each specific sample. Two-dimensional reconstructions on stacks were performed using ImageJ software (http://rsb.info.nih.gov/ij). Images presented in figures are shown without background subtraction.
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Image analysis and quantification
Quantification analyses were performed in blind and sample identity was not revealed until correlations were completed.
In order to evaluate eGFP expression in serotonergic neurons, adult Tph2HeGFP (FRT) þ / À mice were processed for double immunohistochemistry using anti-5-HT and anti-eGFP antibodies as described above. For the analysis of eGFP and 5-HT co-localization in the raphe nuclei, immunoreactive neurons were counted for a total of 2748 neurons on 60 confocal images (40 Â magnification) as a maximal projection of a Z-stack with 10 Z-steps at 0.5 mm intervals. 5 confocal fields on at least 3 adjacent sections were acquired for each raphe region (i.e. B8-B9, B7, B5-B6, B1-B3) of heterozygous animals. À / À mice immunoreacted for eGFP as described above. eGFP-positive neurons were resolved on 20 consecutive sections using the analyze particle function of the ImageJ software. Subsequently, ROD of fluorescence of selected neurons was measured for both Tph2HeGFP (FRT) þ / À and Tph2HeGFP
(FRT)/(FRT-neo-FRT) À / À animals. In order to evaluate density of serotonergic fibers in specific brain areas, ROD measurement was performed in regions of interest in P0, P5, P10, P14, P21 and adult Tph2HeGFP (FRT) þ / À and Tph2HeGFP (FRT)/(FRT-neo-FRT) À / À animals. Images were taken using a low-power objective lens (10 Â ) setting constant acquisition parameters on 5-20 consecutive coronal sections (50 mm thick, 1 area per section) depending on the antero-posterior extension of the structure under analysis. For each experiment, rhodamineconjugated secondary antibody was used to avoid the interference of endogenous eGFP fluorescence in the measurement of ROD. Control adjacent sections were processed in parallel omitting the primary antibody and used to calculate background OD. After conversion to grayscale 8-bit, OD was quantified using ImageJ software drawing a mask with the same area in specific brain regions, in both heterozygous and mutants, and ROD was determined after subtraction of background OD. Results were expressed as ROD value of fibers for both Tph2HeGFP (FRT)/(FRT-neo-FRT) À / À and control Tph2HeGFP (FRT) þ / À samples. For the quantification of BDNF expression, images of autoradiography films resulting from radioactive in situ experiments on animals at postnatal stage P0, P10, P30 and adult of both wild-type and Tph2HeGFP mutant genotypes were scanned at a resolution of 3200 dpi. OD was evaluated in the pyramidal cell layer of Ammon's horn (CA), in the granule cell layer of the dentate gyrus (DG) of the hippocampus, in the paraventricular nucleus and in the cortex on at least 5 sections (14 mm thick) for each region. Background OD value was determined in structures of the same section devoid of specific signal and subtracted for correction to obtain the ROD value for both Tph2HeGFP mutant and control mice. Results were expressed as percentage increase/decrease of BDNF expression in Tph2HeGFP À / À mice as compared to controls.
Quantitative real time PCR
RNA was extracted from adult cortical and hippocampal specimens using TRIzol reagent (Life Technologies), following the manufacturer guidelines. cDNA was obtained from 500 ng of RNA using the Reverse Transcriptase core kit (Eurogentec). Quantitative real-time PCR was performed on 1/100 of the retrotranscription reaction using Mesa green qPCR MasterMix Plus (Eurogentec) and RotorGene 6000 (Corbett Life Science). mRNA quantifications were normalized to the housekeeping gene b-actin and each reaction was performed in three replicates. Sequences of the primers used are available on request. Relative expression changes between conditions were calculated by the comparative Ct method. All changes are shown as percentage of relative expression values.
Statistical analysis
Data are expressed as mean±s.e.m. and tests of significance were conducted using Wilcoxon signed-rank test for unpaired data. Growth rate results were analyzed using analysis of variance (ANOVA) followed by Tukey's post hoc test. Kaplan-Meier survival plots were analyzed using Logrank test. P-values resulting from statistical tests or post-hoc comparisons are indicated.
RESULTS
Generation of the Tph2HeGFP
(FRT-neo-FRT) knock-in mouse allele expressing eGFP in serotonergic neurons A Tph2HeGFP
(FRT-neo-FRT) knock-in mutant allele was generated to disrupt the Tph2 gene and to allow faithful Tph2-like expression of the eGFP reporter. To compare eGFP levels between heterozygotes and homozygotes, the targeting vector was prepared with a FRT-flanked neo cassette cloned in the opposite transcriptional orientation than the eGFP gene to repress the reporter expression within the targeted locus (Figure 1a ). 33 We first evaluated the capability of the neo cassette to repress eGFP expression. Starting from mid-gestation to late postnatal stages, we could not detect any eGFP expression in the brainstem of heterozygous Tph2HeGFP
(FRT-neo-FRT) knock-in mice (Figures 1b,  d-f) . To excise the neo cassette and to generate the recombined Tph2HeGFP (FRT) allele (Figure 1a ), Tph2HeGFP (FRT-neo-FRT) mice were mated to the ACTBHFLPe delete. 28 Interestingly, presence of eGFP was readily observed in Tph2HeGFP (FRT) heterozygous mice starting from 11.5 days post coitum (dpc) embryos to adulthood with a distribution mirroring that of Tph2 mRNA (Figures 1c-g ). Serotonin immunostaining on both Tph2HeGFP
(FRT-neo-FRT) and Tph2HeGFP (FRT) heterozygous animals showed that the distribution of B1-B9 serotonergic neurons was comparable to that of wild-types ( Supplementary Figure 1a (FRT-neo-FRT) þ / À animals were intercrossed to obtain Tph2HeGFP-deficient ( À / À ) mice and effective disruption of Tph2 was confirmed using in situ hybridization and immunohistochemistry (Figures 3a-d) . In line, high-performance liquid chromatography (HPLC) analysis showed a dramatic depletion of 5-HT content in the CNS of mutants (Figure 3e ). Conversely, 5-HT amount in pineal gland, duodenum and whole blood was comparable between mutants and controls ( Figure 3e ). To address the origin of residual brain 5-HT found in Tph2HeGFP-null mice, we used the Evans blue dye method. 29, 34 Importantly, these results demonstrated that in Tph2HeGFP mutants neuronal 5-HT synthesis is abrogated and, in turn, unveil that the remnant amount of this neurotransmitter derived from circulating cerebral blood (Figure 3f ).
Lack of central 5-HT affects survival and growth rate of Tph2HeGFP-null mice Mutants were born at normal Mendelian ratios and did not show at birth any noticeable difference from wild-types and heterozygotes. Strikingly, few days after birth, evidence of a growth rate defect was apparent and about 60% of Tph2HeGFP-null mice from both the pure (C57BL/6-F9) and mixed (129/Ola-C57BL/6) genetic background died within the first 3 weeks after birth ( Supplementary Figure 3a-d) . Although mutants exhibited no obvious deficits in suckling ability showing milk in their stomachs, already at postnatal day 3 (P3) they were significantly smaller than wild-types and heterozygotes and the body weight difference between genotypes continued to increase up to the third week after birth (Po0.001; Supplementary Figure 3d) . After weaning the surviving Tph2HeGFP-null mice slowly approached the weight of their siblings (Supplementary Figure 3d) , they were fertile and showed a normal life span. Subsequently, we analyzed the effect of lack of 5-HT on the development of highly stereotyped anatomical and histological brain structures using both Nissl and cytochrome oxidase staining. Nissl-stained coronal sections throughout the rostro-caudal extent of the brain at P90 appeared undistinguishable between wild-type and mutant animals ( Supplementary Figure 4a and b) . We also screened cytochrome oxidase-stained sections cut tangential to the pial surface from P10 brains and, similarly, no obvious abnormalities were found in Tph2HeGFP-null mice as compared to wild-types ( Supplementary Figure 4c and d) .
We then asked whether development of serotonergic neurons was affected in mice missing the foreseen trophic autocrine action of 5-HT. [35] [36] [37] To address this question we compared the neuroanatomical distribution and the total number of eGFP-expressing neurons in the rhombencephalon of Tph2HeGFP (FRT) þ / À and compound heterozygous Tph2HeGFP (FRT)/(FRT-neo-FRT) À / À mice. First, to exclude that lack of 5-HT affects Tph2 transcriptional activity, thus making levels of eGFP fluorescence not comparable between heterozygotes and homozygotes, we measured relative optical density (ROD) in the somata of eGFP-positive neurons and we found no difference between genotypes ( Supplementary  Figure 4e ). An undistinguishable staining pattern was observed in the two genotypes demonstrating that eGFP-expressing neurons can differentiate and maintain both comparable distribution and normal neuronal shape up to adulthood, despite the absence of 5-HT (Supplementary Figure 4f-i) . Similarly, the number of eGFPexpressing cells in the dorsal and median raphe was unchanged (Supplementary Figure 4j) .
Effects of 5-HT depletion on serotonergic neurite outgrowth in the brain of
To unveil a potential role of 5-HT on the development of serotonergic system, we explored the hodological organization of the raphe nuclei to the rostral brain. Serotonergic innervation was highlighted by immunofluorescence on brain coronal sections of Tph2HeGFP (FRT) þ / À and Tph2HeGFP (FRT)/(FRT-neo-FRT) À / À animals and evaluation of fiber density was performed using densitometric measurements and confocal microscopy analysis. Surprisingly, in the rostral brain of Tph2HeGFP-null mice, we were able to identify three distinct scenarios in which the density of serotonergic fibers appeared reduced (i.e. suprachiasmatic nucleus of the hypothalamus and thalamic paraventricular nucleus), increased (i.e. nucleus accumbens and hippocampus), or unaffected (e.g. cerebral cortex). The cerebral cortex of Tph2HeGFP (FRT) þ / À and Tph2HeGFP À / À mice showed a similar pattern of serotonergic fibers, as highlighted by eGFP-immunoreactivity, from layer I to VI, with a little fluctuant density in distinct layers of specific cortical regions. Accordingly, densitometric analysis of eGFP-immunoreactivity in the parietal cortex (primary somatosensory, S1) resulted in a comparable ROD measured in both Tph2HeGFP (FRT) þ / À and Tph2HeGFP (FRT)/(FRT-neo-FRT) À / À mice (Supplementary Figure 5a) . Moreover, confocal analysis showed a similar path arrangement of serotonergic innervation in the two genotypes ( Supplementary Figure 5b and c) , further confirming unaltered serotonergic projections to the cerebral cortex of 5-HT-depleted mice.
In contrast, serotonergic fibers failed to properly innervate the suprachiasmatic nucleus (SChN) of the hypothalamus and the thalamic paraventricular nucleus (PVN) of Tph2HeGFP mutants. Serotonergic fibers innervating the SChN form a highly stereotyped topographic arrangement as highlighted by eGFP fluorescence in Tph2HeGFP (FRT) þ / À mice (Figures 4a and b) . In the SChN of adult Tph2HeGFP (FRT)/(FRT-neo-FRT) À / À mice, eGFP immunofluorescence was dramatically reduced in intensity as compared to heterozygotes (ROD: À 58% Po0.001; Figures 4a-f; Supplementary Figure 5d ; Table 1 ). Although barely visible, eGFPpositive fibers left in the SChN region depicted a pattern resembling the distribution of serotonergic innervation observed in normal mice (Figures 4b and e) . Furthermore, high magnification confocal images in the medial region of the SChN revealed that the reduction of fluorescence signal was due to a remarkable reduction in the number of varicosities of the residual serotonergic fibers (Figures 4c and f) . Similarly, in Tph2HeGFP-null mice the clustered serotonergic fibers reaching the PVN appeared consistently reduced in their density in the center of the nucleus (ROD: À 42% Po0.001; Supplementary Figure 5d ; Table 1 ), while they resulted trimmed off at the edges (Figures 4g-l ).
An opposite phenotype was found in the nucleus accumbens and hippocampus of mutant brains. Density of serotonergic fibers to the nucleus accumbens shell (NAs) in À / À mice appeared remarkably increased (ROD: þ 64% Po0.001; Supplementary Figure 5d ; Table 1 ) and the crescent-shaped fluorescent territory resulted enlarged on its medio-lateral extent as compared to (Figures 5a-f ). Confocal analysis further confirmed the presence of highly packed axons forming a dense tangle of eGFP-positive fibers (Figures 5b, c, e and f ) . Moreover, supernumerary serotonergic fibers found in the NAs of Tph2HeGFP-null mice appeared to be mainly represented by fibers with thick axonal diameter and characterized by the presence of large varicosities (Figures 5c and f) . In the hippocampus of adult Tph2HeGFP (FRT)/(FRT-neo-FRT) À / À mice, Tph2 enzymatic activity disruption resulted in a marked hyperinnervation that was quantitatively evaluated in adults for each of the four layers in both dorsal and ventral hippocampal regions (Figures 5g-r) . Comparison of eGFP-immunoreactivity between the two genotypes revealed an overall significant increase of the density of 5-HT axons in all the hippocampal layers analyzed (Po0.001). Interestingly, we reported a higher hyperinnervation in the ventral hippocampal region of each layer as compared to the dorsal counterpart. Specifically, the density of the serotonergic fibers in the stratum oriens of the dorsal and the ventral hippocampus of Tph2HeGFP (FRT)/(FRT-neo-FRT) À / À mice was þ 25 and þ 47% of that measured in heterozygotes, respectively. Similarly, the ROD in the dorsal and the ventral hippocampus of 5-HT-depleted mice was þ 40 and þ 41% in the stratum radiatum, þ 39 and þ 44% in the stratum lacunosummoleculare, and þ 32 and þ 49% in the molecular layer of dentate gyrus ( Supplementary Figure 5d ; Table 1 ).
To identify the timing of the appearance of the observed abnormalities we extended our analysis to fetal and early postnatal stages. In both Tph2HeGFP
(FRT) þ / À and Tph2HeGFP Table 1 ). We then asked whether the three distinct scenarios of serotonergic fiber density we observed in Tph2HeGFP Up-regulated BDNF expression in the hippocampus of Tph2HeGFP mutant mice A number of experimental evidences suggests brain derived neurotrophic factor (BDNF) as a crucial molecule in promoting development and establishment of neural circuitry of the serotonergic system. [38] [39] [40] We assessed BDNF mRNA expression levels by quantitative RT-PCR (qRT-PCR) in hippocampus and cortex of wild-type, Tph2HeGFP þ / À and À / À adult mice. Interestingly, we found a significant increase of BDNF expression in the hippocampus of mutant animals as compared to wild-types ( þ 27%, Po0.05) and heterozygotes, while in the cortex of serotoninlacking brains it appeared unchanged (Figure 6a) . Furthermore, to explore more in detail the districts in which BDNF mRNA was overexpressed we performed ISH using 35 S-radiolabeled antisense BDNF probe on brain coronal sections of both wild-type and Tph2HeGFP À / À adult mice. In the hippocampus of mutant mice, the intensity of the autoradiographic signal appeared noticeably higher as compared to controls (Figures 6b-e) , showing a remarkable and significant increase of BDNF expression in both the pyramidal cell layer of Ammon's horn (CA) and the granule cell layer of the dentate gyrus (DG; Figure 6f ). We observed that the extent of the BDNF overexpression was higher in the ventral hippocampal region ( þ 72 and þ 42% in the pyramidal and granule cell layer, respectively, Po0.001) as compared to the dorsal region ( þ 26 and þ 30% in the pyramidal and granule cell layer, respectively, Po0.001; Figure 6f ). Conversely, in other areas in which BDNF is expressed such as cortex and PVN, BDNF mRNA levels in Tph2HeGFP mutants were undistinguishable from that of wild-types (Figure 6f ). Finally, to investigate when BDNF overexpression was first detectable in Tph2HeGFP À / À mice, we performed a time-course analysis of BDNF expression on brain coronal sections of both wild-type and Tph2HeGFP À / À animals, starting from P0, by means of radioactive ISH. Remarkably, quantitative analyses showed that BDNF overexpression in the hippocampus started as early as P10 (CA: þ 20% Po0.001; DG: þ 24% Po0.001), paralleling the timing of the appearance of serotonergic hyperinnervation (Figure 6f ).
DISCUSSION
Here we report that lack of central serotonin affects postnatal development, and that serotonin is crucial for the correct establishment of the serotonergic neurite projections during critical periods of neuronal wiring. Our findings reveal that serotonergic circuitry formation shows high susceptibility to serotonin levels in specific areas of the rostral brain that can be causally associated to the control of behaviors altered in psychiatric disorders including schizophrenia and anxiety.
Genetic disruption of the brain serotonin biosynthetic enzyme Tph2 resulted, in our Tph2HeGFP mouse line, in a dramatic growth impairment that is comparable in extent to what reported in other Tph2 knockouts. 19, 22 Our results showed that the weight at birth of mutant animals did not differ from that of wild-type and heterozygous littermates, indicating that lack of brain serotonin does not affect fetal growth and development but rather impacts on early postnatal life. In light of the pleiotropic action of serotonin, the origin of growth retardation may be multifactorial Table 1 . Analysis of eGFP-positive serotonergic fiber density in Tph2HeGFP-null animals : stratum oriens þ 25% (***, dorsal hippocampus), þ 47% (***, ventral hippocampus); stratum radiatum þ 40% (***, dorsal hippocampus), þ 41% (***, ventral hippocampus); stratum lacunosum-moleculare þ 39% (***, dorsal hippocampus), þ 44% (***, ventral hippocampus); molecular layer of dentate gyrus þ 32% (***, dorsal hippocampus), þ 49% (***, ventral hippocampus). n.s.: difference not significant, P-value40.05; (*), P-valueo0.05; (**), P-valueo0.01; (***), P-valueo0.001.
Serotonin depletion affects serotonergic innervation S Migliarini et al
and two main non-exclusive reasons might account for the observed deficit, nutritional and/or metabolic. The former hypothesis according to which dysphagia or hypophagia would be at the origin of the growth deficiency appears weakened by the evidence that we found normal amount of milk in the stomach of mutants and the fact that even the early removal of competing siblings did not improve the phenotype. By contrast, a metabolic cause for the growth retardation is well supported by the marked reduction of insulin-like growth factor-1 (IGF1) levels in serum, as showed by Alenina and co-workers. 19 Accordingly, the finding that Serotonin depletion affects serotonergic innervation S Migliarini et al normal IGF1 levels are restored after two months of age is in agreement with the observation that growth curves are nearly parallel after weaning, with the weight of mutant animals that approaches that of controls around P90. 19 Our results on the reduced survival rate are in line with what reported by Alenina and collaborators but we could neither explain the reasons of early death observed in Tph2HeGFP mutant pups nor exclude the growth impairment being at the origin of the premature lethality. Interestingly, recent findings have shown that serotonin deficit alters autonomic circuits causing lethality in animal models displaying some features of sudden infant death syndrome (SIDS). 41 Thus, further studies will be required to determine whether the early postnatal lethality shown by Tph2HeGFP mutant animals might be associated to facets of SIDS.
Support to a role for serotonin in brain development comes from data showing that perturbation of serotonergic signaling affects CNS development and that precise serotonin levels are crucial for normal neuroanatomy and cytoarchitecture establishment. 9, 12 However, mouse models in which serotonin was depleted via Tph2 inactivation failed to show abnormalities in CNS development. 19, 20, 22, 23 In line, our data showed that lack of brain serotonin results neither in detectable alterations of brain neuroanatomy nor in changes of serotonergic neuron development within the raphe nuclei. Therefore, a provocative view is that serotonin is not required for brain development. Support to this paradoxical hypothesis comes from the absence of overt CNS developmental abnormalities in serotonin receptor knock-out mice. 9 Nevertheless, studies from both vertebrate and invertebrate organisms have supported the idea that serotonin regulates neurite outgrowth and establishment of neuronal connectivity during development. [42] [43] [44] [45] [46] The availability of the Tph2HeGFP knock-in mice allowed for the first time to highlight serotonergic fibers irrespective of serotonin immunoreactivity and made possible to visualize directly the development and the formation of the serotonergic neuronal circuitry. Thanks to the presence of strong eGFP fluorescence, our mouse model made possible for the first time to perform accurate analyses of axonal projections of serotonergic neurons in animals lacking brain serotonin. Absence of brain serotonin resulted in overt alterations of serotonergic innervation in several regions of the rostral brain. Intriguingly, besides the apparently normal distribution observed in cortex and striatum (not shown), development of serotonin axon terminal arborization exhibited, as a consequence of Tph2 inactivation, a diametrically opposite response in distinct brain areas. Specifically, we reported a dramatic reduction of serotonergic innervation in the suprachiasmatic nucleus and in the thalamic paraventricular nucleus. Conversely, an extensive axon terminal arborization resulting in a serotonergic hyperinnervation was observed in the nucleus accumbens and in the hippocampus of Tph2HeGFP mutant adult mice. These results demonstrate that brain serotonin has an important role in regulating the wiring of the serotonergic system during brain development and that serotonin can act either promoting or inhibiting serotonergic axon terminal arborization relying on specific target brain districts. Moreover, the maintenance of eGFP-synaptophysin-positive varicosities in Tph2HeGFP mutants suggests that serotonergic fibers might preserve the functional competence for neurotransmission despite the lack of serotonin.
In vertebrates, the timing of development and the establishment of ascending serotonergic innervation proceed with a sequential pattern that can be subdivided into three phases. 5 During the first two phases serotonin axons grow out from serotonergic nuclei defining the primary pathway development and by the end of gestation selective pathways have developed reaching all the brain structures that will receive serotonergic innervation. An active sprouting of serotonin axon terminals exhibiting differential regional and temporal arborization and proceeding within the first three weeks after birth characterizes the third phase (terminal field development). 5 An intriguing question is whether serotonin acts throughout the development of the serotonergic innervation or whether specific developmental phases, particularly sensitive to serotonin modulation, exist. At P0, serotonergic projections of Tph2HeGFP mutants have reached all brain districts, weakening the possibility of a specific serotonergic pathway rerouting. This evidence, rather, strongly suggests that serotonin exerts its role during the period of terminal field development either promoting or inhibiting sprouting of serotonin axon terminals. Support to this hypothesis comes from the fact that the abnormal sprouting of serotonin axon terminals matches the temporal progression of terminal field development. In fact, suprachiasmatic and thalamic paraventricular nuclei, in which the establishment of serotonergic innervation is completed by P10, 5 showed already at P5 the fiber density reduction seen in adult mutants; whereas, in the hippocampus, in which serotonergic terminal field matures over a more protracted time span, 5 we observed a progressive increase of hyperinnervation that starts from P10 and peaks in adult mice.
Although the precise mechanism through which serotonin acts to modulate the development of axon terminal arborization is unknown, activation of specific serotonin receptors is likely to play a pivotal role. Both pharmacological and genetic results provided evidences that specific serotonin receptors mediate the trophic effects of serotonin. [46] [47] [48] Therefore, the complex and vast operational heterogeneity of the serotonergic system signaling, 49 together with the dynamic spatio-temporal expression of serotonin receptors during brain development, [50] [51] [52] may account for the opposite effects of serotonin on serotonergic fiber formation. This view suggests that serotonin has an autoregulatory role on the serotonergic axon terminal arborization with selective, brain region-and time-dependent, trophic effects. Similarly, in several invertebrate systems, serotonin depletion altered serotonergic fiber development without precluding normal differentiation of serotonergic neurons. 42, 53, 54 Overall, these data disclose the presence of an autoregulatory control mediated by serotonin that is conserved throughout animal evolution.
The evidence that Tph2HeGFP À / À mice showed an altered arborization of serotonergic terminals raised the question of how the lack of serotonin induces sprouting defects. We demonstrated a clear up-regulation of the endogenous BDNF expression in the hippocampus that starts from P10 and mirrors the timing of the appearance of the marked serotonergic hyperinnervation. These findings are in good agreement with a large body of evidences showing a neurotrophic effect of BDNF upon serotonergic axons. Cerebral infusion of BDNF promotes sprouting of serotonergic axons at the site of injection. 39, 40 Conversely, BDNF downregulation observed in BDNF þ / À mice causes a decrement in the serotonergic fiber density in the hippocampus. 38 Together with the well-known action of BDNF on the serotonergic system, our results about the effects of serotonin depletion on BDNF expression unmask a possible regulatory feedback mechanism through which serotonin itself might regulate the formation of the serotonergic neuronal circuitry in the hippocampus. Reduction of serotonin levels may trigger increased endogenous BDNF signaling that in turn exerts a neurotrophic effect upon serotonergic axons. A higher density of serotonergic axon terminals would result in additional serotonin release sites and, likely, in an augmented availability of serotonin, thus restoring the original BDNF levels that, consequently, would turn down the serotonergic axon sprouting. A recent report by Hill and collaborators provides strong support to this hypothesis and suggests that serotonin would modulate BDNF levels via the activation of the 5-HT2C receptor. 55 In conclusion, our results demonstrate that serotonin, besides its role as a neurotransmitter, represents an important signal required during CNS development involved in the formation of the highly precise architecture of the nervous system and in particular in the fine tuning for patterning the correct serotonergic branching at selected regions of the brain. We also found that depletion of serotonin resulted in an up-regulation of BDNF expression in the hippocampus, thus matching the observed hyperinnervation. These findings indicate that homeostasis of serotonin is required to establish the complex network of serotonin release sites. The evidence that serotonin levels are crucial for the proper wiring of the brain contributes to confirm that exposure to genetic, pharmacological or environmental insults altering the serotonergic signaling produces long-lasting changes that may prompt to neuropsychiatric disorders thought to have developmental origins such as schizophrenia, autism and mental retardation.
